DARA Biosciences Reports Waiver of Product Granted, Fees by FDA Established By: Benzinga via Benzinga January 06, 2015 at 08:03 AM EST DARA BioSciences, Inc. (NASDAQ: DARA), an oncology supportive care pharmaceutical company dedicated to providing healthcare ... Read More >>